Vir Biotechnology (VIR) AGM 2026 summary

Opening remarks and agenda

• Meeting opened by the CEO, welcoming participants and introducing the virtual format for equal participation rights.

• Board members and key executives were introduced, with special recognition for a departing board member and announcement of a new Board Chair.

• The agenda included formal business as set forth in the notice and proxy statement.

Board and executive committee updates

• Board committee roles and memberships were outlined, including changes in Board Chair and committee assignments.

• Acknowledgment of service by a retiring board member and transition of Board Chair responsibilities.

Shareholder proposals

• Three proposals were presented: election of three Class I Directors, advisory approval of executive compensation, and ratification of the independent auditor.

• Details of each proposal and the nominees for director positions were provided.